Daniel H Deck
Overview
Explore the profile of Daniel H Deck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ignatius E, Rimal B, Panthi C, Belz D, Lippincott C, Deck D, et al.
mSphere
. 2024 Jul;
9(7):e0038124.
PMID: 38980071
Treatment outcomes for (, also known as ) disease are still unsatisfactory, mainly due to issues with drug toxicity, tolerability, and efficacy. Treating disease is challenging due to its high...
2.
Serio A, Deck D, Wright K, Manion K
Antimicrob Agents Chemother
. 2024 Jun;
68(7):e0063824.
PMID: 38888320
No abstract available.
3.
Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease
Rimal B, Panthi C, Xie Y, Belz D, Ignatius E, Lippincott C, et al.
Tuberculosis (Edinb)
. 2024 Feb;
146:102482.
PMID: 38364332
Mycobacteroides abscessus (Mab, also known as Mycobacterium abscessus) causes opportunistic pulmonary and soft tissue infections that are difficult to cure with existing treatments. Omadacycline, a new tetracycline antibiotic, exhibits potent...
4.
Zurawski D, Serio A, Black C, Pybus B, Akers K, Deck D, et al.
Mil Med
. 2023 Nov;
189(5-6):e1353-e1361.
PMID: 37963013
Introduction: Combat-related wound infections complicate the recovery of wounded military personnel, contributing to overall morbidity and mortality. Wound infections in combat settings present unique challenges because of the size and...
5.
Rimal B, Nicklas D, Panthi C, Lippincott C, Belz D, Ignatius E, et al.
mSphere
. 2023 Mar;
8(2):e0066522.
PMID: 36912629
Mycobacteroides abscessus is an opportunistic pathogen in people with structural lung conditions such as bronchiectasis, chronic obstructive pulmonary disease, and cystic fibrosis. Pulmonary M. abscessus infection causes progressive symptomatic and...
6.
Lauterio M, Deck D
J Fam Pract
. 2022 Jul;
71(5 Suppl):S2-S9.
PMID: 35776861
Skin and soft tissue infections (SSTI) and community-acquired pneumonia (CAP) are major public health problems that are commonly encountered in the primary care setting. Establishing the severity of disease is...
7.
Ramirez J, Deck D, Eckburg P, Curran M, Das A, Kirsch C, et al.
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab135.
PMID: 34160474
Background: Severity/mortality risk scores and disease characteristics may assist in deciding whether patients with community-acquired bacterial pneumonia (CABP) require outpatient treatment or hospitalization. The phase 3 OPTIC (Omadacycline for Pneumonia...
8.
Deck D, Jordan J, Holland T, Fan W, Wikler M, Sulham K, et al.
Infect Dis Ther
. 2016 Aug;
5(3):363-5.
PMID: 27565805
No abstract available.
9.
Deck D, Jordan J, Holland T, Fan W, Wikler M, Sulham K, et al.
Infect Dis Ther
. 2016 Jul;
5(3):353-61.
PMID: 27370913
Introduction: Introduction of new antibiotics enabling single-dose administration, such as oritavancin may significantly impact site of care decisions for patients with acute bacterial skin and skin structure infections (ABSSSI). This...
10.
Doernberg S, Winston L, Deck D, Chambers H
Clin Infect Dis
. 2012 May;
55(5):615-20.
PMID: 22563022
Background: Receipt of antibiotics is a major risk factor for Clostridium difficile infection (CDI). Doxycycline has been associated with a lower risk for CDI than other antibiotics. We investigated whether...